Artwork

محتوای ارائه شده توسط Newstalk ZB. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Newstalk ZB یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Dr Michelle Dickinson: nanotechnologist on the new eye drop treatment that promises to restore vision loss

3:51
 
اشتراک گذاری
 

Manage episode 507579407 series 2500324
محتوای ارائه شده توسط Newstalk ZB. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Newstalk ZB یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

If you’ve found yourself holding a book at arm’s length or squinting at your phone in dim light, you’re not alone. Almost everyone develops presbyopia as they get older. It’s a natural part of aging where the eye’s lens loses flexibility, making it harder to focus on nearby objects.

Traditionally, the go-to solution has been reading glasses, or, for some, surgery. But now, a surprising contender is on the horizon: eye drops.

At the recent Congress of the European Society of Cataract and Refractive Surgeons, researchers presented results that could change how presbyopia is treated. In a study of 766 patients, eye drops combining pilocarpine and diclofenac helped people read extra lines on a near-vision chart, and the improvements lasted for up to two years.

The drops contain two active ingredients working in tandem:

  • Pilocarpine: an older drug that contracts the eye’s ciliary muscle and makes the pupil smaller. This helps sharpen focus for near objects.
  • Diclofenac: a common anti-inflammatory drug that eases the discomfort pilocarpine can cause.

Together, they act like a workout and cushion for the eye: one trains the focusing muscles, the other keeps irritation at bay.

Patients in the study used the drops twice a day once in the morning and once later in the afternoon, with the option for a third dose if needed.

The findings were striking:

  • Within one hour of the first dose, patients could typically read three extra lines on the near-vision chart.
  • 99% of those using the lowest concentration (1% pilocarpine) gained at least two lines of improvement.
  • For many, the improvements lasted more than a year, with some maintaining better vision for nearly two years.
  • Side effects were mild and included temporary dim vision (32%), irritation (3.7%), and headaches (3.8%). Importantly, no serious complications like retinal detachment were reported.

Imagine a future where instead of fumbling for your reading glasses at dinner, you simply use an eye drop in the morning and carry on with clear sight throughout the day.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

3101 قسمت

Artwork
iconاشتراک گذاری
 
Manage episode 507579407 series 2500324
محتوای ارائه شده توسط Newstalk ZB. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Newstalk ZB یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

If you’ve found yourself holding a book at arm’s length or squinting at your phone in dim light, you’re not alone. Almost everyone develops presbyopia as they get older. It’s a natural part of aging where the eye’s lens loses flexibility, making it harder to focus on nearby objects.

Traditionally, the go-to solution has been reading glasses, or, for some, surgery. But now, a surprising contender is on the horizon: eye drops.

At the recent Congress of the European Society of Cataract and Refractive Surgeons, researchers presented results that could change how presbyopia is treated. In a study of 766 patients, eye drops combining pilocarpine and diclofenac helped people read extra lines on a near-vision chart, and the improvements lasted for up to two years.

The drops contain two active ingredients working in tandem:

  • Pilocarpine: an older drug that contracts the eye’s ciliary muscle and makes the pupil smaller. This helps sharpen focus for near objects.
  • Diclofenac: a common anti-inflammatory drug that eases the discomfort pilocarpine can cause.

Together, they act like a workout and cushion for the eye: one trains the focusing muscles, the other keeps irritation at bay.

Patients in the study used the drops twice a day once in the morning and once later in the afternoon, with the option for a third dose if needed.

The findings were striking:

  • Within one hour of the first dose, patients could typically read three extra lines on the near-vision chart.
  • 99% of those using the lowest concentration (1% pilocarpine) gained at least two lines of improvement.
  • For many, the improvements lasted more than a year, with some maintaining better vision for nearly two years.
  • Side effects were mild and included temporary dim vision (32%), irritation (3.7%), and headaches (3.8%). Importantly, no serious complications like retinal detachment were reported.

Imagine a future where instead of fumbling for your reading glasses at dinner, you simply use an eye drop in the morning and carry on with clear sight throughout the day.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

3101 قسمت

Tous les épisodes

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع

در حین کاوش به این نمایش گوش دهید
پخش